Peptide
Liraglutide
Liraglutide is used or studied for weight loss; glucose control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
In depth
How it works
Liraglutide was one of the first GLP-1 receptor agonists to reach the market. Structurally modified from human GLP-1 to resist rapid breakdown, it requires once-daily dosing rather than the once-weekly schedule of newer GLP-1 drugs, but works through the same receptor pathway: slowed gastric emptying, increased insulin secretion, and appetite suppression.
What the research shows
Liraglutide has two FDA-approved brand formulations — Victoza for type 2 diabetes and Saxenda (a higher dose) for chronic weight management — and a long clinical track record since its original 2010 approval. Weight-loss trials have generally shown 4–6 kg average reductions, more modest than newer once-weekly GLP-1 drugs, but backed by more years of post-market safety data.
The most common reasons for discontinuation are gastrointestinal: nausea and vomiting account for the largest share of dropouts in clinical trials.
Detail
Overview
Liraglutide is used or studied for weight loss; glucose control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Benefits, side effects, and protocols
Benefits list
- Weight loss
- glucose control
Side effects
- Nausea
- vomiting
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- High
- Popular obesity treatment
Regulatory
- Fda Approved
- Prescription required
Research
Mechanisms
Evidence notes
- High
- Popular obesity treatment
Administration
Research links
Contraindications
- None listed
Components
- None listed
Regulatory data
- Fda Approved
- Prescription required
Aliases
- None listed
Used in these stacks
Related compounds
Half-life
How long does Liraglutide stay in your system?
Half-life ≈ 13 hours — see what remains after any number of days, and when it is practically cleared.
Guides that cover Liraglutide
Terminology on this page
Concepts from the glossary that come up around Liraglutide.
A deliberately modified version of a natural peptide, altered to change its stability, potency, or duration.
Glucagon-like peptide-1 — an incretin hormone that increases insulin secretion, slows gastric emptying, and reduces appetite.
The rate at which food leaves the stomach; GLP-1 drugs slow it, which drives both satiety and nausea.
Frequently asked questions
Is liraglutide the same as Ozempic?
No. Liraglutide (Victoza, Saxenda) and semaglutide (Ozempic, Wegovy) are different GLP-1 receptor agonist molecules from different manufacturers. Liraglutide requires daily dosing while semaglutide is dosed weekly.
How much weight loss does liraglutide produce?
Clinical trials of Saxenda (the weight-management formulation) have generally shown average weight loss in the 4–6 kg range over the trial period, less than newer once-weekly GLP-1 drugs but with a longer safety track record.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Liraglutide? Check your source before you use anything.